According to a recent LinkedIn post from Vektor Medical Inc, the company has been selected to participate in MedTech Innovator’s Radar Forum. The post notes that Vektor Medical is among more than 140 ventures that passed the program’s initial diligence filters to pitch in front of over 200 judges, investors, strategic partners, and clinicians.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that CEO Rob Krummen is scheduled to present Vektor’s story at the event and discuss how its vMap technology is influencing electrophysiology (EP) labs and patient outcomes. For investors, participation in this curated MedTech forum may increase Vektor Medical’s visibility with potential funding sources and strategic collaborators, potentially supporting future capital access and validation of its EP-focused offering.